litlas
ログインアカウント作成

Stephen L. Hauser

1975–2025 年に発表

別表記
Stephen L Hauser
213
論文数
47,397
被引用数
111
h 指数
206
i10 指数

被引用数

Stephen L. Hauser の年別被引用数1973 年: 被引用 2 件1975 年: 被引用 1 件1976 年: 被引用 1 件1977 年: 被引用 2 件1978 年: 被引用 5 件1979 年: 被引用 5 件1980 年: 被引用 6 件1981 年: 被引用 11 件1982 年: 被引用 13 件1983 年: 被引用 19 件1984 年: 被引用 14 件1985 年: 被引用 22 件1986 年: 被引用 19 件1987 年: 被引用 16 件1988 年: 被引用 29 件1989 年: 被引用 18 件1990 年: 被引用 26 件1991 年: 被引用 19 件1992 年: 被引用 13 件1993 年: 被引用 16 件1994 年: 被引用 14 件1995 年: 被引用 28 件1996 年: 被引用 43 件1997 年: 被引用 84 件1998 年: 被引用 104 件1999 年: 被引用 121 件2000 年: 被引用 116 件2001 年: 被引用 159 件2002 年: 被引用 142 件2003 年: 被引用 120 件2004 年: 被引用 130 件2005 年: 被引用 162 件2006 年: 被引用 163 件2007 年: 被引用 144 件2008 年: 被引用 277 件2009 年: 被引用 308 件2010 年: 被引用 418 件2011 年: 被引用 369 件2012 年: 被引用 331 件2013 年: 被引用 335 件2014 年: 被引用 334 件2015 年: 被引用 374 件2016 年: 被引用 327 件2017 年: 被引用 371 件2018 年: 被引用 496 件2019 年: 被引用 1,321 件2020 年: 被引用 1,503 件2021 年: 被引用 1,619 件2022 年: 被引用 1,478 件2023 年: 被引用 1,122 件2024 年: 被引用 1,883 件2025 年: 被引用 1,006 件2026 年: 被引用 31 件1974 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,559 件、この内訳の 25.8%イギリス: 引用元論文 1,404 件、この内訳の 7.9%ドイツ: 引用元論文 1,376 件、この内訳の 7.8%イタリア: 引用元論文 979 件、この内訳の 5.5%カナダ: 引用元論文 868 件、この内訳の 4.9%中国: 引用元論文 793 件、この内訳の 4.5%スイス: 引用元論文 651 件、この内訳の 3.7%フランス: 引用元論文 594 件、この内訳の 3.4%スペイン: 引用元論文 576 件、この内訳の 3.2%オーストラリア: 引用元論文 567 件、この内訳の 3.2%オランダ: 引用元論文 528 件、この内訳の 3%スウェーデン: 引用元論文 394 件、この内訳の 2.2%
0%25.8%その他 24.9%

機関

分野

  • Medicine56.7%
  • Biochemistry, Genetics and Molecular Biology21%
  • Immunology and Microbiology10.1%
  • Neuroscience8.9%
  • Agricultural and Biological Sciences0.6%
  • Computer Science0.4%
  • その他2.3%

トピック

  • Multiple Sclerosis Research Studies13.5%
  • T-cell and B-cell Immunology4.1%
  • Peripheral Neuropathies and Disorders3.8%
  • Neuroinflammation and Neurodegeneration Mechanisms3.5%
  • Immunotherapy and Immune Responses2.6%
  • Immune Cell Function and Interaction2.2%
  • その他70.3%

共著者

全論文

検索で開く
  1. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

    著者: Stephen L. Hauser, Amit Bar‐Or, Gıancarlo Comı, Gavin Giovannoni, Hans‐Peter Hartung, Bernhard Hemmer, Fred Lublin, Xavier Montalbán, Kottil Rammohan, Krzysztof Selmaj, Anthony Traboulsee, Jerry S. Wolinsky, Douglas L. Arnold, Gaëlle Klingelschmitt, Donna Masterman, Paulo Fontoura, Shibeshih Belachew, Peter Chin, Nicole Mairon, Hideki Garren, Ludwig Kappos - New England Journal of Medicine 2016 被引用: 1,961

  2. Treatment of Multiple Sclerosis: A Review

    著者: Stephen L. Hauser, Bruce Cree - The American Journal of Medicine 2020 被引用: 938

  3. Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials

    著者: Ludwig Kappos, Jerry S. Wolinsky, Gavin Giovannoni, Douglas L. Arnold, Qing Wang, Corrado Bernasconi, Fabian Model, Harold Koendgen, Marianna Manfrini, Shibeshih Belachew, Stephen L. Hauser - JAMA Neurology 2020 被引用: 622

  4. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

    著者: Xavier Montalbán, Stephen L. Hauser, Ludwig Kappos, Douglas L. Arnold, Amit Bar‐Or, Giancarlo Comi, de Sèze, Gavin Giovannoni, Hans‐Peter Hartung, Bernhard Hemmer, Fred Lublin, Kottil Rammohan, Krzysztof Selmaj, Anthony Traboulsee, Annette Sauter, Donna Masterman, Paulo Fontoura, Shibeshih Belachew, Hideki Garren, Nicole Mairon, Peter Chin, Jerry S. Wolinsky - New England Journal of Medicine 2016 被引用: 1,856

  5. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models

    著者: Egle Cekanaviciute, Bryan B. Yoo, Tessel F. Runia, Justine W. Debelius, Sneha Singh, Charlotte Nelson, Rachel Kanner, Yadira Bencosme, Yun Kyung Lee, Stephen L. Hauser, Elizabeth Crabtree‐Hartman, Ilana Katz Sand, Mar Gacias, Yunjiao Zhu, Patrizia Casaccia, Bruce Cree, Rob Knight, Sarkis K. Mazmanian, Sergio E. Baranzini - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 被引用: 1,050

  6. Ofatumumab versus Teriflunomide in Multiple Sclerosis

    著者: Stephen L. Hauser, Amit Bar‐Or, Jeffrey Cohen, Gıancarlo Comı, Jorge Correale, Patricia K. Coyle, Anne H. Cross, de Sèze, David Leppert, Xavier Montalbán, Krzysztof Selmaj, Heinz Wiendl, Cécile Kerloëguen, Roman Willi, Bingbing Li, Algirdas Kakarieka, Davorka Tomic, Alexandra Goodyear, Ratnakar Pingili, Dieter A. Häring, Krishnan Ramanathan, Martin Merschhemke, Ludwig Kappos - New England Journal of Medicine 2020 被引用: 700

  7. Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course

    著者: Xiaoyuan Zhou, Ryan Baumann, Xiaohui Gao, Myra Mendoza, Sneha Singh, Ilana Katz Sand, Zongqi Xia, Laura M. Cox, Tanuja Chitnis, Hongsup Yoon, Laura Moles, Stacy J. Caillier, Adam Santaniello, Gail Ackermann, Adil Harroud, Robin Lincoln, Refujia Gomez, Antonio González Peña, Elise Digga, Daniel Hakim, Yoshiki Vázquez‐Baeza, Karthik Soman, Shannon Warto, Greg Humphrey, Mauricio Farez, Lisa Ann Gerdes, Jorge R. Oksenberg, Scott S. Zamvil, Siddharthan Chandran, Peter Connick, David Otaegui, Tamara Castillo‐Triviño, Stephen L. Hauser, Jeffrey M. Gelfand, Howard L. Weiner, Reinhard Hohlfeld, Hartmut Wekerle, Jennifer Graves, Amit Bar‐Or, Bruce Cree, Jorge Correale, Rob Knight, Sergio E. Baranzini - Cell 2022 被引用: 319

  8. B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

    著者: Stephen L. Hauser, Emmanuelle Waubant, Douglas L. Arnold, Timothy R. Vollmer, Jack P. Antel, Robert J. Fox, Amit Bar‐Or, Michael Panzara, Neena Sarkar, Sunil Agarwal, Annette Langer‐Gould, Craig H. Smith - New England Journal of Medicine 2008 被引用: 2,399

  9. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial

    著者: Ari Green, Jeffrey M. Gelfand, Bruce Cree, Carolyn Bevan, W. John Boscardin, Feng Mei, Justin Inman, Sam Arnow, Michael Devereux, Aya Abounasr, Hiroko Nobuta, Alyssa H. Zhu, Matt Friessen, Roy Gerona, H.‐Christian von Büdingen, Roland G. Henry, Stephen L. Hauser, Jonah R. Chan - The Lancet 2017 被引用: 577

  10. Silent progression in disease activity–free relapsing multiple sclerosis

    著者: Bruce Cree, Jill A. Hollenbach, Riley Bove, Gina Kirkish, Simone Sacco, Eduardo Caverzasi, Antje Bischof, Tristan Gundel, Alyssa H. Zhu, Nico Papinutto, W. Stern, Carolyn Bevan, Andrew R. Romeo, Douglas S. Goodin, Jeffrey M. Gelfand, Jennifer Graves, Ari Green, Michael R. Wilson, Scott S. Zamvil, Chao Zhao, Refujia Gomez, Nicholas R. Ragan, Gillian Rush, Patrick Barba, Adam Santaniello, Sergio E. Baranzini, Jorge R. Oksenberg, Roland G. Henry, Stephen L. Hauser - Annals of Neurology 2019 被引用: 455

  11. Role of B Cells in Multiple Sclerosis and Related Disorders

    著者: Gıancarlo Comı, Amit Bar‐Or, Hans Lassmann, Antonio Uccelli, Hans‐Peter Hartung, Xavier Montalbán, Per Solberg Sørensen, Reinhard Hohlfeld, Stephen L. Hauser - Annals of Neurology 2020 被引用: 278

  12. KIR + CD8 + T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19

    著者: Jing Li, Maxim Zaslavsky, Yapeng Su, Jing Guo, Michael J. Sikora, Vincent van Unen, Asbjørn Christophersen, Shin‐Heng Chiou, Liang Chen, Jun Li, Xuhuai Ji, Julie Wilhelmy, Alana M. McSween, Brad A. Palanski, Vamsee Mallajosyula, Nathan A. Bracey, Gopal Krishna Dhondalay, Kartik Bhamidipati, Joy A. Pai, Lucas Kipp, Jeffrey Dunn, Stephen L. Hauser, Jorge R. Oksenberg, Ansuman T. Satpathy, William H. Robinson, Cornelia L. Dekker, Lars M. Steinmetz, Chaitan Khosla, Paul J. Utz, Ludvig M. Sollid, Yueh‐hsiu Chien, James R. Heath, Nielsen Fernandez‐Becker, Kari C. Nadeau, Naresha Saligrama, Mark M. Davis - Science 2022 被引用: 245

  13. Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis

    著者: Feng Mei, Stephen P.J. Fancy, Yun‐An Shen, Jianqin Niu, Chao Zhao, Bryan Presley, Edna Miao, Seonok Lee, Sonia R. Mayoral, Stephanie Redmond, Ainhoa Etxeberría, Lan Xiao, Robin J.M. Franklin, Ari Green, Stephen L. Hauser, Jonah R. Chan - Nature Medicine 2014 被引用: 590

  14. Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

    著者: Walter J. Curran, Rebecca Paulus, Corey J. Langer, R. Komaki, Jong Seok Lee, Stephen L. Hauser, B. Movsas, Todd H. Wasserman, Seth A. Rosenthal, Elizabeth Gore, Mitchell Machtay, William T. Sause, James D. Cox - JNCI Journal of the National Cancer Institute 2011 被引用: 1,235

  15. Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions

    著者: Colm Elliott, Jerry S. Wolinsky, Stephen L. Hauser, Ludwig Kappos, Frederik Barkhof, Corrado Bernasconi, Wei Wei, Shibeshih Belachew, Douglas L. Arnold - Multiple Sclerosis Journal 2018 被引用: 214

  16. Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial

    著者: Kathleen Hawker, Paul O’Connor, Mark S. Freedman, Peter A. Calabresi, Jack P. Antel, Jack H. Simon, Stephen L. Hauser, Emmanuelle Waubant, Timothy Vollmer, Hillel Panitch, Jiameng Zhang, Peter Chin, Craig H. Smith, OLYMPUS trial group - Annals of Neurology 2009 被引用: 939

  17. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis

    著者: Colm Elliott, Shibeshih Belachew, Jerry S. Wolinsky, Stephen L. Hauser, Ludwig Kappos, Frederik Barkhof, Corrado Bernasconi, Julian Fecker, Fabian Model, Wei Wei, Douglas L. Arnold - Brain 2019 被引用: 215

  18. Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials

    著者: Amit Bar‐Or, Gian‐Andrea Thanei, Christopher Harp, Corrado Bernasconi, Ulrike Bonati, Anne H. Cross, Saloumeh K Fischer, Laura Gaetano, Stephen L. Hauser, Robert L. Hendricks, Ludwig Kappos, Jens Kühle, David Leppert, Fabian Model, Annette Sauter, Harold Koendgen, Xiaoming Jia, Ann Herman - EBioMedicine 2023 被引用: 88

  19. Gut microbiota–specific IgA + B cells traffic to the CNS in active multiple sclerosis

    著者: Anne‐Katrin Pröbstel, Xiaoyuan Zhou, Ryan Baumann, Sven Wischnewski, Michael Kutza, Olga L. Rojas, Katrin Sellrie, Antje Bischof, Kicheol Kim, Akshaya Ramesh, Ravi Dandekar, Ariele L. Greenfield, Ryan Schubert, Jordan E. Bisanz, Stephanie Vistnes, Khashayar Khaleghi, James Landefeld, Gina Kirkish, Friederike Liesche‐Starnecker, Valeria Ramaglia, Sneha Singh, Edwina B. Tran, Patrick Barba, Kelsey C. Zorn, Johanna Oechtering, Karin Forsberg, Lawrence R. Shiow, Roland G. Henry, Jennifer Graves, Bruce Cree, Stephen L. Hauser, Jens Kühle, Jeffrey M. Gelfand, Peter M. Andersen, Jürgen Schlegel, Peter J. Turnbaugh, Peter H. Seeberger, Jennifer L. Gommerman, Michael R. Wilson, Lucas Schirmer, Sergio E. Baranzini - Science Immunology 2020 被引用: 219

  20. Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis

    著者: Stephen L. Hauser, Ludwig Kappos, Xavier Montalbán, Licínio Craveiro, Cathy Chognot, Richard A. Hughes, Harold Koendgen, Noemi Pasquarelli, Ashish Pradhan, Kalpesh Prajapati, Jerry S. Wolinsky - Neurology 2021 被引用: 177

  21. Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis

    著者: Ahmed Abdelhak, Pascal Benkert, Sabine Schaedelin, W. John Boscardin, Christian Cordano, Johanna Oechtering, Kirtana Ananth, Cristina Granziera, Lester Melie‐García, Shivany Condor Montes, Alexandra Beaudry‐Richard, Lutz Achtnichts, Frederike Cosima Oertel, Patrice H. Lalive, David Leppert, Stefanie Müller, Roland G. Henry, Caroline Pot, Amandine Matthias, Anke Salmen, Jorge R. Oksenberg, Giulio Disanto, Chiara Zecca, Marcus D’Souza, Renaud Du Pasquier, Claire Bridel, Claudio Gobbi, Ludwig Kappos, Stephen L. Hauser, Bruce Cree, Jens Kühle, Ari Green, UCSF, MS EPIC, and the SMSC Study Teams, Sergio E. Baranzini, Riley Bove, Michael R. Wilson, Jill A. Hollenbach, Refujia Gomez, Adam Santaniello, Meagan Harms, Tiffany Cooper, Stacy J. Caillier, Johannes Lorscheider, Alessandro Cagol, Muhamed Baraković, Riccardo Galbusera, Özgür Yaldizli, Suvitha Subramaniam, Annette Orleth, Tobias Derfuß, Aleksandra Maleska Maceski, Eline A.J. Willemse, Lars G. Hemkens, Perrine Janiaud, Lilian Demuth, Bettina Fischer‐Barnicol, Robert Hoepner, Andrew Chan, Oliver Findling - JAMA Neurology 2023 被引用: 91

  22. Five years of ocrelizumab in relapsing multiple sclerosis

    著者: Stephen L. Hauser, Ludwig Kappos, Douglas L. Arnold, Amit Bar‐Or, Bruno Brochet, Robert T. Naismith, Anthony Traboulsee, Jerry S. Wolinsky, Shibeshih Belachew, Harold Koendgen, Victoria Levesque, Marianna Manfrini, Fabian Model, Stanislas Hubeaux, Lahar Mehta, Xavier Montalbán - Neurology 2020 被引用: 158

  23. CAR-T Cell–Mediated B-Cell Depletion in Central Nervous System Autoimmunity

    著者: Sasha Gupta, Milos Simic, Sharon A. Sagan, Chanelle Shepherd, Jason Duecker, Raymond A. Sobel, Ravi Dandekar, Gregory F. Wu, Wesley Wu, John E. Pak, Stephen L. Hauser, Wendell A. Lim, Michael R. Wilson, Scott S. Zamvil - Neurology Neuroimmunology & Neuroinflammation 2023 被引用: 66

  24. Long‐term evolution of multiple sclerosis disability in the treatment era

    著者: Bruce Cree, Pierre‐Antoine Gourraud, Jorge R. Oksenberg, Carolyn Bevan, Elizabeth Crabtree‐Hartman, Jeffrey M. Gelfand, Douglas S. Goodin, Jennifer Graves, Ari Green, Ellen M. Mowry, Darin T. Okuda, Daniel Pelletier, H.‐Christian von Büdingen, Scott S. Zamvil, Alisha Agrawal, Stacy J. Caillier, Caroline Ciocca, Refujia Gomez, Rachel Kanner, Robin Lincoln, Antoine Lizée, Pamela Qualley, Adam Santaniello, Leena Suleiman, Monica Bucci, Valentina Panara, Nico Papinutto, W. Stern, Alyssa H. Zhu, Gary Cutter, Sergio E. Baranzini, Roland G. Henry, Stephen L. Hauser - Annals of Neurology 2016 被引用: 436